Does a physician or advanced practice provider need to be on site when antineoplastics are being administered?

Created by Faye Team, Modified on Wed, 03 Jan 2024 at 11:10 AM by Jaime Weimer

The ASCO/ONS Chemotherapy Administration Safety Standards address creating a safe staffing environment and state a licensed independent practitioner needs to be on-site and immediately available to staff who administer chemotherapy in the healthcare setting (Neuss et al., 2016). 

The Centers for Medicare and Medicaid Services state that chemotherapy and radiation administration require direct supervision. The physician or advanced provider providing supervision must be immediately available and interruptible to provide assistance and direction throughout the performance of the procedure; however, he or she does not need to be in the room when the procedure is performed (Saulet, 2018).


ONS/ASCO standards (Neuss et al., 2016) also state that two chemotherapy-competent professionals be present at the time administration is initiated to complete independent double checks of antineoplastic orders and administration settings. 


Neuss, M.N., Gilmore, T.R., Belderson, K.M., Billett, A.L., Conti-Kalchik, T., Harvey, B.E., . . . Polovich, M. (2016). 2016 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology. Oncology Nursing Forum, 44(1), 31-43

Saulet, D. (2018). The advisory board: What you need to know about Medicare’s physician supervision requirements. Retrieved from

Was this article helpful?

That’s Great!

Thank you for your feedback

Sorry! We couldn't be helpful

Thank you for your feedback

Let us know how can we improve this article!

Select atleast one of the reasons
CAPTCHA verification is required.

Feedback sent

We appreciate your effort and will try to fix the article